![Acute myeloid leukemia cell membrane-coated nanoparticles for cancer vaccination immunotherapy | Leukemia Acute myeloid leukemia cell membrane-coated nanoparticles for cancer vaccination immunotherapy | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-021-01432-w/MediaObjects/41375_2021_1432_Fig1_HTML.png)
Acute myeloid leukemia cell membrane-coated nanoparticles for cancer vaccination immunotherapy | Leukemia
![Leukemia-on-a-chip: Dissecting the chemoresistance mechanisms in B cell acute lymphoblastic leukemia bone marrow niche | Science Advances Leukemia-on-a-chip: Dissecting the chemoresistance mechanisms in B cell acute lymphoblastic leukemia bone marrow niche | Science Advances](https://www.science.org/cms/asset/6dba215e-82d9-4e44-a37e-e596c10aed87/aba5536-f1.gif)
Leukemia-on-a-chip: Dissecting the chemoresistance mechanisms in B cell acute lymphoblastic leukemia bone marrow niche | Science Advances
National Cancer Institute - A genetic change called the Philadelphia chromosome is used as a tumor marker in some types of leukemia to confirm diagnosis, predict response to targeted therapy, and monitor
![Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy - eBioMedicine Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy - eBioMedicine](https://www.thelancet.com/cms/attachment/b080d5c9-8fa6-4142-a015-31d6aaabb2eb/gr1_lrg.jpg)
Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy - eBioMedicine
![Frontiers | Novel Markers in Pediatric Acute Lymphoid Leukemia: The Role of ADAM6 in B Cell Leukemia Frontiers | Novel Markers in Pediatric Acute Lymphoid Leukemia: The Role of ADAM6 in B Cell Leukemia](https://www.frontiersin.org/files/Articles/706129/fcell-09-706129-HTML-r1/image_m/fcell-09-706129-t001.jpg)